BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 17960617)

  • 21. CpG island hypermethylation in cell-free serum DNA identifies patients with localized prostate cancer.
    Ellinger J; Haan K; Heukamp LC; Kahl P; Büttner R; Müller SC; von Ruecker A; Bastian PJ
    Prostate; 2008 Jan; 68(1):42-9. PubMed ID: 18004747
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impact of hormonal therapy on the detection of promoter hypermethylation of the detoxifying glutathione-S-transferase P1 gene (GSTP1) in prostate cancer.
    Kollermann J; Kempkensteffen C; Helpap B; Schrader M; Krause H; Muller M; Miller K; Schostak M
    BMC Urol; 2006 Jun; 6():15. PubMed ID: 16803634
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Quantitative GSTP1 hypermethylation in bodily fluids of patients with prostate cancer.
    Jerónimo C; Usadel H; Henrique R; Silva C; Oliveira J; Lopes C; Sidransky D
    Urology; 2002 Dec; 60(6):1131-5. PubMed ID: 12475696
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cell-free DNA and RNA in plasma as a new molecular marker for prostate and breast cancer.
    Papadopoulou E; Davilas E; Sotiriou V; Georgakopoulos E; Georgakopoulou S; Koliopanos A; Aggelakis F; Dardoufas K; Agnanti NJ; Karydas I; Nasioulas G
    Ann N Y Acad Sci; 2006 Sep; 1075():235-43. PubMed ID: 17108217
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Gene promoter methylation in prostate tumor-associated stromal cells.
    Hanson JA; Gillespie JW; Grover A; Tangrea MA; Chuaqui RF; Emmert-Buck MR; Tangrea JA; Libutti SK; Linehan WM; Woodson KG
    J Natl Cancer Inst; 2006 Feb; 98(4):255-61. PubMed ID: 16478744
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hypermethylation of the CpG islands in the promoter region of the GSTP1 gene in prostate cancer: a useful diagnostic and prognostic marker?
    Bernardini S; Miano R; Iori R; Finazzi-Agrò E; Palmieri G; Ballerini S; Angeloni C; Orlandi A; Bellincampi L; Cortese C; Federici G
    Clin Chim Acta; 2004 Dec; 350(1-2):181-8. PubMed ID: 15530476
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Promoter hypermethylation of the tumor-suppressor genes RASSF1A, GSTP1 and CDH1 in endometrial cancer.
    Fiolka R; Zubor P; Janusicova V; Visnovsky J; Mendelova A; Kajo K; Lasabova Z; Plank L; Danko J
    Oncol Rep; 2013 Dec; 30(6):2878-86. PubMed ID: 24068440
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Aberrant Promoter Hypermethylation of RASSF1a and BRCA1 in Circulating Cell-Free Tumor DNA Serves as a Biomarker of Ovarian Carcinoma.
    S SK; Swamy SN; Premalatha CS; Pallavi VR; Gawari R
    Asian Pac J Cancer Prev; 2019 Oct; 20(10):3001-3005. PubMed ID: 31653147
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Borderline and malignant phyllodes tumors display similar promoter methylation profiles.
    Kim JH; Choi YD; Lee JS; Lee JH; Nam JH; Choi C; Park MH; Yoon JH
    Virchows Arch; 2009 Dec; 455(6):469-75. PubMed ID: 19924440
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Gene promoter methylation and its potential relevance in early prostate cancer diagnosis.
    Steiner I; Jung K; Schatz P; Horns T; Wittschieber D; Lein M; Dietel M; Erbersdobler A
    Pathobiology; 2010; 77(5):260-6. PubMed ID: 21116117
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical significance of promoter hypermethylation of DNA repair genes in tumor and serum DNA in invasive ductal breast carcinoma patients.
    Sharma G; Mirza S; Parshad R; Srivastava A; Gupta SD; Pandya P; Ralhan R
    Life Sci; 2010 Jul; 87(3-4):83-91. PubMed ID: 20470789
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Methylation of multiple genes in prostate cancer and the relationship with clinicopathological features of disease.
    Singal R; Ferdinand L; Reis IM; Schlesselman JJ
    Oncol Rep; 2004 Sep; 12(3):631-7. PubMed ID: 15289848
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A tissue biopsy-based epigenetic multiplex PCR assay for prostate cancer detection.
    Van Neste L; Bigley J; Toll A; Otto G; Clark J; Delrée P; Van Criekinge W; Epstein JI
    BMC Urol; 2012 Jun; 12():16. PubMed ID: 22672250
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Methylation analysis of BRCA1, RASSF1, GSTP1 and EPHB2 promoters in prostate biopsies according to different degrees of malignancy.
    Rabiau N; Thiam MO; Satih S; Guy L; Kemeny JL; Boiteux JP; Fontana L; Bignon YJ; Bernard-Gallon D
    In Vivo; 2009; 23(3):387-91. PubMed ID: 19454503
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Association of circulating tumor cells with tumor-related methylated DNA in patients with hormone-refractory prostate cancer.
    Okegawa T; Nutahara K; Higashihara E
    Int J Urol; 2010 May; 17(5):466-75. PubMed ID: 20337729
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In silico mining identifies IGFBP3 as a novel target of methylation in prostate cancer.
    Perry AS; Loftus B; Moroose R; Lynch TH; Hollywood D; Watson RW; Woodson K; Lawler M
    Br J Cancer; 2007 May; 96(10):1587-94. PubMed ID: 17453001
    [TBL] [Abstract][Full Text] [Related]  

  • 37. DNA Methylation-Guided Prediction of Clinical Failure in High-Risk Prostate Cancer.
    Litovkin K; Van Eynde A; Joniau S; Lerut E; Laenen A; Gevaert T; Gevaert O; Spahn M; Kneitz B; Gramme P; Helleputte T; Isebaert S; Haustermans K; Bollen M
    PLoS One; 2015; 10(6):e0130651. PubMed ID: 26086362
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Global Hypomethylation (LINE-1) and Gene-Specific Hypermethylation (GSTP1) on Initial Negative Prostate Biopsy as Markers of Prostate Cancer on a Rebiopsy.
    Zelic R; Fiano V; Zugna D; Grasso C; Delsedime L; Daniele L; Galliano D; Pettersson A; Gillio-Tos A; Merletti F; Richiardi L
    Clin Cancer Res; 2016 Feb; 22(4):984-92. PubMed ID: 26475336
    [TBL] [Abstract][Full Text] [Related]  

  • 39. GSTP1 hypermethylation as a molecular marker in the diagnosis of prostatic cancer: is there a correlation with clinical stage, Gleason grade, PSA value or age?
    Bastian PJ; Ellinger J; Schmidt D; Wernert N; Wellmann A; Müller SC; von Rücker A
    Eur J Med Res; 2004 Nov; 9(11):523-7. PubMed ID: 15649863
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Methylation of APC and GSTP1 in non-neoplastic tissue adjacent to prostate tumour and mortality from prostate cancer.
    Richiardi L; Fiano V; Grasso C; Zugna D; Delsedime L; Gillio-Tos A; Merletti F
    PLoS One; 2013; 8(7):e68162. PubMed ID: 23874531
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.